GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pilulka Lekarny as PINK.PR · CZK

Consumer Staples · Prague · 🇨🇿 Czechia

Compare

79.00

-3.66%

Close of 9 Nov 2026, in CZK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Pilulka Lekarny as

Its shares trade on Prague under the ticker PINK.PR. It has been listed since 26 October 2020. In the fiscal year to 31 December 2025, it reported revenue of CZK 876.4m and a net loss of CZK 38.9m. At that date it held total assets of CZK 197.1m and shareholders' equity of −CZK 133.8m.

Pilulka Lékárny as operates retail and online pharmacy stores. The company is headquartered in Praha, Praha. The company went IPO on 2020-10-26. The network of pharmacies under the Pilulka Lekarny brand was established at the beginning of 2015 and is part of pharmaceutical group in the Czech Republic and Slovakia.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Listed since
26 Oct 2020
Employees
383
Website
pilulka.cz ↗

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Established pharmacy network since 2015 in Czech Republic and Slovakia
  • 383 full-time employees supporting retail and online operations
  • IPO on 26 October 2020 providing market access

Weaknesses

  • Limited to Czech Republic and Slovakia markets
  • No mention of international expansion plans
  • Dependent on pharmaceutical group structure

Opportunities

  • Growing demand for online pharmacy services in Central Europe
  • Expanding retail presence in Prague and surrounding areas
  • Potential for new product lines in health care sector

Threats

  • Competition from larger pharmacy chains in Czech Republic
  • Regulatory changes affecting pharmaceutical sales
  • Economic downturn impacting consumer spending on health care

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.